Histone Deacetylase Inhibitors for Purging HIV-1 from the Latent Reservoir

Documenti analoghi

• Reactivation of latent HIV by histone deacetylase inhibitors
  di: Shirakawa, Kotaro, et al.
  Pubblicazione: (2013)
• The Histone Deacetylase Inhibitor ITF2357 Decreases Surface CXCR4 and CCR5 Expression on CD4+ T-Cells and Monocytes and is Superior to Valproic Acid for Latent HIV-1 Expression in Vitro
  di: Matalon, Shay, et al.
  Pubblicazione: (2010)
• Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors
  di: Sahu, Gautam K, et al.
  Pubblicazione: (2011)
• Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
  di: Martínez-Bonet, Marta, et al.
  Pubblicazione: (2015)
• Inhibitors of Histone Deacetylases: CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV TYPE 1 (HIV-1) FROM LATENTLY INFECTED CELLS
  di: Huber, Kelly, et al.
  Pubblicazione: (2011)